Study of Inflammatory Cells in the Blood and Cerebral Thrombus of Patients Affected by Cerebral Ischemia
Not yet recruitingOBSERVATIONAL
Enrollment
380
Participants
Timeline
Start Date
June 30, 2025
Primary Completion Date
May 31, 2030
Study Completion Date
May 31, 2030
Conditions
Stroke Acute
Trial Locations (1)
Unknown
Neurology, Milan
All Listed Sponsors
collaborator
University of Zurich
OTHER
collaborator
University of Manchester
OTHER
collaborator
German Cancer Research Center
OTHER
lead
IRCCS San Raffaele
OTHER
NCT07033988 - Study of Inflammatory Cells in the Blood and Cerebral Thrombus of Patients Affected by Cerebral Ischemia | Biotech Hunter | Biotech Hunter